(Q51559550)

7 April 2018

title

Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value. (English)

1 reference

7 April 2018

1 reference

1 reference

Chadarevian R

1

1 reference

7 April 2018

Bruckert E

2

1 reference

7 April 2018

Dejager S

3

1 reference

7 April 2018

Presberg P

4

1 reference

7 April 2018

Turpin G

5

1 reference

7 April 2018

publication date

1 November 1999

1 reference

7 April 2018

published in

Thrombosis Research

1 reference

7 April 2018

volume

96

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

175-182

1 reference

7 April 2018

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Coagulation factor VII and the risk of coronary heart disease in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Fibrinolytic and thrombotic factors in atherosclerosis and IHD: the influence of triglyceride rich lipoproteins (TGRLP)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Hypertriglyceridemia and regulation of fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

LDL particle size distribution. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900089-4

7 January 2021

10.1016/S0049-3848(99)00089-4

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018